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BRIEF REPORTS

Process Evaluation of an Early-Intervention Program
for Mood and Anxiety Disorders Among Older
Adolescents and Young Adults
Elizabeth A. Osuch, M.D., Evelyn Vingilis, Ph.D., Carolyn Summerhurst, M.S.W., Christeen I. Forster, M.S.W.,
Erin E. Ross, Ph.D., Andrew J. Wrath, B.A.

Objective: Research to determine the best approach for
providing early intervention for mood and anxiety disorders
is imperative. The authors describe a process evaluation of
an early-intervention program for transition-age youths with
mood or anxiety disorders.
Methods: Causal and logic models for pathways to care for
the program, as well as descriptive data from 548 participating youths, are presented. Follow-up measures of functional improvement are reported.
Results: Diagnostic characterization, symptom severity, and
functional impairment of participants indicated that the model

Best practice for the treatment of chronic or recurring
illness is early identiﬁcation and intervention to reduce
personal and social burden, including cost of lifetime
disability (1). Early intervention has increasingly been
adopted by public health services worldwide as a strategy for
treatment of chronic illnesses (2). In psychiatry, ﬁrst-episode
psychosis initiatives have shown some beneﬁts (3).
The absence of early treatment for mood and anxiety
disorders can worsen prognosis (4). Yet, little research is
available on early intervention for these disorders, despite their high prevalence and heavy symptom burden (5).
Consensus is growing that early-intervention programs for
mood and anxiety disorders are needed (6), and in the
United States, an ongoing congressional initiative advocates
mental health care services for transition-age youths (7).
Without effective delivery models, these efforts could be
wasted.
The objective of this study was to conduct a process
evaluation of an early-intervention program that we developed for mood and anxiety disorders among transitionage youths. The study aimed to determine if this delivery
model was being implemented as intended in terms of
assessment activities, treatment, and referrals and was
Psychiatric Services 66:10, October 2015

selected an appropriate catchment population without creating
excessive overinclusion. Self-referred youths reported greater
anxiety and substance use. Acceptance by the program was
predictive of greater follow-through with treatment. Several
variables, including frequent lifetime marijuana use, predicted
loss to follow-up. At follow-up, youths were signiﬁcantly
functionally improved.
Conclusions: This process evaluation indicated that the model
provided appropriate early intervention for youths with mood
or anxiety disorders without causing excessive overinclusion.
Psychiatric Services 2015; 66:1113–1117; doi: 10.1176/appi.ps.201400256

providing an appropriate level of coverage of its target
audience.
METHODS
The First-Episode Mood and Anxiety Program (FEMAP)
was designed to reduce barriers for youths seeking help for
signiﬁcant mood or anxiety concerns. A formative evaluation
of the causal and logic models of FEMAP was published
previously (8). [Modiﬁed versions of the models are available
as an online supplement to this report.] This report relates
to steps 2–4 of phase I of the causal model; the community
outreach component (step 1) of phase I was described previously and has remained unchanged (8).
FEMAP was designed for youths already experiencing
symptoms severe enough to warrant specialty services. In
that sense, “ﬁrst episode” is euphemistic. Phase I contains
several unique aspects, including location in a youth-friendly
setting; an option for self-referral; detailed assessment to
determine placement in the correct treatment setting and
to build rapport between youths and clinical staff; use of
clinical case conferences to determine optimal treatment;
and rapid enrollment in FEMAP, facilitation of referral to
ps.psychiatryonline.org
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alternative services—if indicated—or reassurance if no specialized treatment appears warranted.
Initial assessment was conducted during in-person, customary clinical interviews by a licensed, master’s-level social
worker (CS or CF) or psychologist (ER) with diagnostic,
symptom, situational, and functional assessments. At the conclusion of the interview, participants completed research questionnaires. Most participants completed the questionnaire in
person, but, occasionally, a questionnaire was completed by
phone or e-mail. A participant’s diagnostic category was determined by these clinical interviews and questionnaires. A
clinical case conference ensued to establish optimal treatment
for each patient and the urgency of treatment.
Youths ages 16 to 26 were enrolled. All participants either
were referred by a physician or contacted FEMAP without a physician’s referral. Youths with lifetime medication
treatment lasting longer than 18 months were excluded because using medication for that length of time is an indicator
of having received signiﬁcant care from a previous psychiatric provider or service. Youths with developmental delays,
major general medical problems, history of head injury resulting in a signiﬁcant period of unconsciousness, and lengthy
medication use for treatment of attention-deﬁcit hyperactivity
disorder (ADHD) were excluded and referred to alternative
services. Youths who endorsed psychiatric symptoms that began
only after signiﬁcant alcohol or illicit drug use were referred to
community addiction services and excluded. Youths evaluated
to be in imminent danger to self or others were immediately
referred to emergency services until they were more stable.
All youths who presented to FEMAP between October 2009
and November 2012 were asked to enroll. Willing participants
signed written consent to participate, as approved by the
Human Research Ethics Board for the University of Western
Ontario.
Measures included the Beck Depression Inventory–II
(BDI); the State Trait Anxiety Inventory (STAI); the Sheehan
Disability Scale (SDS); the Structured Clinical Interview for
DSM-IV screening questionnaire for substance use, anxiety,
and eating disorders; the Emotion Regulation Questionnaire
(ERQ); the National Institute on Drug Abuse Alcohol, Smoking and Substance Involvement Screening Test (NIDA
ASSIST)–Prescreen V1.0; the Adult ADHD Self-Report
Scale, version 1.1, part A (ASRS); and the Youth Risk Behavior
Survey (YRBS). A demographic screening questionnaire developed by the investigators recorded participants’ emotional
concerns, psychiatric treatment history, and demographic
characteristics (8).
Three months or longer after initial contact with FEMAP,
participants were contacted for follow-up, regardless of
acceptance to or treatment at FEMAP. Three attempts
were made to contact each participant at scheduled clinical
appointments or by phone or e-mail. The follow-up consisted of a questionnaire about their original mental health
concern or concerns, interval changes to mental health and
addiction diagnoses and treatments, and their experiences
with their mental health treatment. In addition, the SDS was
1114
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readministered to evaluate functional impairment. The followup was conducted to assess patient follow-through with recommendations during phase I of the causal model and not to
evaluate the effectiveness of treatment per se.
All statistical analyses used SPSS, version 21. Missing data
were omitted from individual analyses.
RESULTS
Of 830 youths who presented for services, 560 (67%) youths
agreed to participate in research; the remaining youths were
treated identically but did not participate in data collection;
there was no incentive for participation. Results are reported
for 548 youths (12 youths had extensive missing data).
Of the 548 youths, 399 (73%) were accepted to FEMAP,
and 149 (28%) were referred to more appropriate services or,
in rare cases, were reassured only. In both subgroups (accepted and not accepted), approximately two-thirds were
female (N5243, 61%, and N598, 66%, respectively), and
most came without a physician’s referral (N5241, 60%, and
N591, 61%, respectively), had received prior treatment
(N5253, 63%, and N589, 60%, respectively), and had received medication (N5206 and N577, respectively, 52%
each). [Tables summarizing demographic and clinical characteristics, including referral sources, of the youths are available in the online supplement.] No between-group differences
in demographic and clinical characteristics were found, although a trend indicated that accepted youths were more
likely to complete the follow-up questionnaires.
Accepted participants were more likely than those who
were not accepted to have a presumptive diagnosis in a mood
or anxiety disorder category (p,.001), indicating that the
assessment model correctly identiﬁed appropriate youths.
Youths with presumed diagnoses that fell in categories
outside the mood and anxiety categories were less likely to
be accepted. Diagnosis of a primary substance use disorder
was low, as expected, given that having such was a criterion for exclusion. Nevertheless, over 50% of all participants
were at moderate or high risk of a substance use problem.
[A table summarizing the participants’ presumptive diagnostic
categories is available in the supplement.]
The severity of depression symptoms at intake was high,
both for youths who were accepted by FEMAP and youths
who were not accepted (Table 1). Anxiety was moderate for
both subgroups. SDS scores indicated clinical concern for
both groups. Compared with youths who were not accepted
by FEMAP, accepted youths had higher ratings for depression (F55.4, df51 and 527, p5.02); worse scores on the
ERQ, indicating poorer emotional regulation (F515.1, df51
and 529, p,.001); and greater functional impairment on the
SDS (F55.7, df51 and 519, p5.018) but did not differ on
other measures. Youths who were not referred by a physician had higher scores on the STAI (F58.5 df51, p5.004),
indicating greater anxiety, and the NIDA ASSIST (F53.8,
df51, p5.05), indicating higher risk of drug and alcohol use,
compared with youths who were referred by a physician.
Psychiatric Services 66:10, October 2015
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There was no difference in severity of func- TABLE 1. Scores at intake on measures of symptom severity and functional
a
tional impairment on the SDS between the impairment among 548 study participants, by measure and outcome
Measure and outcome
N
Minimum
Maximum
M
SD
p
physician-referred youths and the youths
who came without a physician referral.
.02
BDIb
Among youths who completed follow-up
Accepted
385
0
58
31.2
11.6
Referred or reassured
143
2
59
28.5
12.5
questionnaires, FEMAP-accepted youths
were more likely than youths who were STAIc
Accepted
385
20
78
55.8
11.7
not accepted to FEMAP to follow through
Referred or reassured
142
20
80
54.6
12.7
with recommendations made at initial intake
d
,.001
(x2530.6, df51, p,.001). About half of all ERQ
Accepted
387
–22
35
4.6
8.7
youths (N5282, 51.5%) completed follow-up
Referred or reassured
143
–16
36
7.8
8.4
questionnaires, consistent with follow-up
NIDA ASSISTe
rates in other adolescent research (9). SixAccepted
391
0
158
13.7
20.6
teen independent variables were hypotheReferred or reassured
142
0
128
12.2
19.5
sized to relate to follow-up loss. After removing ASRSf
redundant (highly correlated) and noncontriAccepted
390
0
6
3.4
1.6
Referred or reassured
142
0
6
3.4
1.8
butory (Spearman correlation) variables, eight
.018
remained. Binary logistic regression was per- SDSg
Accepted
382
0
30
20.4
5.9
formed to assess the impact of these remaining
Referred or reassured
138
1
30
18.9
6.8
variables, measured at study entry, on absence
a
Outcomes included acceptance by the ﬁrst-episode mood and anxiety program, referral to
of follow-up. Included were gender, ﬁnal premore appropriate services, or reassurance that specialty services were not indicated.
sumptive diagnosis, lifetime marijuana use, b Beck Depression Inventory–II. Scores from 0–13 indicate minimal depression; 14–19, mild
physician referral or no physician referral, acdepression; 20–28, moderate depression; and 29–63, severe depression.
c
State Trait Anxiety Inventory. Possible scores range from 20 to 80, with higher scores indicating
cepted versus referred or reassured, parental
greater anxiety.
marital status, ASRS score, and ERQ score.
d
Emotion Regulation Questionnaire. Possible scores range from –22 to 46, with higher scores
The full model was statistically signiﬁcant
indicating better emotional regulation.
e
National Institute on Drug Abuse Alcohol, Smoking and Substance Involvement Screening
(x2549.3, df519, p,.001) and correctly classiTest–Prescreen V1.0. Possible scores range from 0 to 390, with 0–3 indicating lower risk; 4–26,
ﬁed the follow-up status of 63% of cases. Three
moderate risk; and $27, high risk.
variables were statistically signiﬁcant: lifetime f Adult ADHD Self-Report Scale, version 1.1, part A. Possible scores range from 0–3, unlikely risk
use of marijuana, driven primarily by the 164 gof ADHD, to 4–6, consistent with ADHD.
Sheehan Disability Scale. Possible scores range from 0, not at all impaired, to 30, extremely
youths who endorsed using marijuana on 100
impaired; any score over 5 warrants clinical attention.
or more occasions (odds ratio [OR]51.88, 95%
conﬁdence interval [CI]51.13–3.13, compared
with no use); having unmarried or non-cohabiting parents
transition-age youths with mood or anxiety concerns. This
(OR51.56, CI51.06–2.30, compared with married parents); and
model offered a unique approach by virtue of being located in
entry into FEMAP without a physician’s referral (OR5.67,
the community and being easily and independently accessible
CI5.46–.99, compared with physician’s referral), suggesting
to youths. It included a detailed, in-person intake assessment
that self-referral was protective against loss to follow-up.
with a skilled clinician and a case conference to optimize treatPreliminary evaluation of clinical improvement was conment initiation. Recommendations and assistance related to
ducted by comparing SDS scores at intake and follow-up for
accessing the most appropriate treatment—FEMAP or other
all youths who completed the SDS at both time points. A
programs—were provided.
repeated-measures, general linear model with one withinThe model did not demand training of clinicians beyond
subjects factor (time) and one between-subjects factor
the standard required by their disciplines for mental health
(accepted versus referred or reassured) was used to assess
care specialists. It preserved the services of the most highly
improvement associated with three related dependent variapaid professionals (psychiatrists) until phase II of the model,
bles (SDS subscales for school or work, social, and family).
after needs were fully determined in phase I. A self-referral
Multivariate results showed a main effect for time (F523.1,
option and careful initial assessment facilitated quicker acdf53, p,.001) and no other main effects or interactions.
cess to optimal services, including triage for immediacy of
Univariate results showed improvement on school or work
need. If alternative services were needed, FEMAP provided
(F562.3, df51, p,.001), social (F530.4, df51, p,.001),
facilitation. This practice has been referred to as “open door”
and family (F524.1, df51, p,.001) subscales.
access, with an expectation that “every door is the right
door” (10). Because of this policy, youths did not have to ask
for help multiple times from multiple agencies, which delays
DISCUSSION
treatment and engenders frustration and extra costs.
One potential unintended consequence of a self-referral
This process evaluation assessed implementation and coveroption is overcoverage (11), the inclusion of patients who do
age of the ﬁrst phase of a novel early-intervention model for
Psychiatric Services 66:10, October 2015
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not require specialized services, resulting in increased wait
times for more severely ill patients and increased cost by
overutilizing high-cost professionals. Our data showed that
at least 60% of youths in both subgroups had already received some form of treatment and over 50% had already
received medication. Yet symptom severity and functional
impairment remained high, implying that previous treatment had not been successful. This was true regardless of
whether youths received a physician’s referral. Of note, acceptance rates were identical regardless of whether youths
were referred by a physician, suggesting that nonphysicians
(including youths themselves) were no worse than physicians at identifying FEMAP as the correct treatment setting.
Thus we found no evidence to support that allowing selfreferrals leads to overcoverage.
Detailed, in-person clinical assessment ensured that youths
who were better served elsewhere (27%) were identiﬁed and
referred or, rarely, were reassured that specialty services were
not indicated. FEMAP-accepted youths were more likely than
youths who received referrals or reassurance to have had
symptoms consistent with mood or anxiety disorders and
higher depression scores, poorer emotion-regulation styles,
and more functional impairment. Again, this pattern suggests that coverage was appropriate, given that the model
captured youths in need of specialty services for mood and
anxiety. FEMAP-accepted youths were somewhat more likely
to complete follow-up and were signiﬁcantly more likely to
follow through with recommendations if they completed followup, potentially because of greater commitment. Differences in
clinical characteristics preclude deﬁnitive explanation for these
differences.
Many individuals who came directly to the program may
have eventually found their way to FEMAP through a doctor’s referral. However, requiring a referral utilizes more
physician time and ensures a longer wait until needed mental
health treatment is provided. By removing added delay
and physician contact, allowing self-referrals may facilitate
overall efﬁciency at no additional, or even at reduced, health
care cost. A probable prerequisite for savings, however, is
careful clinical evaluation at intake to determine the proper
services for patients’ needs before a subspecialty physician is
engaged.
Loss to follow-up was substantial, a ﬁnding that was
closely representative of other research with adolescents (9).
There were several predictors of follow-up loss. Most signiﬁcant was lifetime use of marijuana, deﬁned as use on
more than 100 occasions, which was endorsed by a substantial subgroup of participants. Thus, although substance
use, in general, appeared to increase the likelihood that youths
entered FEMAP without a physician’s referral, lifetime marijuana use increased the likelihood that they would not complete
follow-up. Nevertheless, seeking services without a physician’s
referral was more likely to protect against loss to follow-up
overall. This ﬁnding may reﬂect additional “buy in” among
youths who had chosen to contact FEMAP without a physician’s referral or may be related to other factors.
1116
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Among youths who completed the SDS at both intake and
follow-up, functioning improved. Because there was no control
group, it is impossible to attribute this improvement to FEMAP.
One limitation of this research is related to follow-up,
given that only half of the youths provided follow-up information, perhaps because the study did not provide incentives
for the participants to do so. Another potential limitation was
some undercoverage bias associated with the reality that eligible youths may not contact FEMAP or may contact FEMAP
but decline to participate. Youths often heard about the service through school, doctors, or word of mouth. Individuals
who had little contact with such sources would be less likely
to ﬁnd the service, although Internet usage could have directed them to it.
CONCLUSIONS
Demands for clinically effective and cost-appropriate models of early intervention for youths with moderate to severe
mental illness are growing. This process evaluation of the
initial phase of one such model illustrates that the mental
health care needs of youths with moderate to severe mental
illness can be identiﬁed effectively. The model provides an
approach to assessing mood and anxiety disorders associated
with clinically signiﬁcant symptoms and functional impairment before the symptoms become severe and chronic. The
results showed that the model achieved its desired goals
without excessive overutilization of specialty services. Future evaluation of the therapeutic effectiveness and costeffectiveness of this model, as described in phase 2 of the
causal model, is warranted.
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